Back to 
BlackRock, Inc.
BlackRock, Inc.
TRVI7 quarters
Position history for BlackRock, Inc.'s holdings in Trevi Therapeutics, Inc.
BlackRock, Inc. holds 11.2M shares of TRVI (Trevi Therapeutics, Inc.), worth $208M as of 2026-Q2. The position was increased (+8.9% shares). TRVI represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$208M
Current Shares
11.2M
Total Value Change
+$191.9M
Total Shares Change
+7.2M
Quarter-by-Quarter History
Other major holders of TRVI: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD CAPITAL MANAGEMENT LLC